e potential of adult human mesenchymal stem cells [J]. Science, 1999, 284(5411): 143-147.
[8]王 忠,高 毅,汪 艳,等. 人骨髓间充质干细胞的分离培养与鉴定 [J]. 中华神经医学杂志,2006,5(10):973-977.
[9]Arruda VR, Stedman HH, Nichols TC, et al. Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model [J]. Blood, 2005, 105(9): 3458-3464.
[10]Carter PJ, Samulski RJ. Adeno-associated viral vectors as gene delivery vehicles [J]. Int J Mol Med, 2000, 6(1): 17-27.
[11]Gao G, Vandenberghe LH, Wilson JM. New recombinant serotypes of AAVvectors[J]. Curr Gene Ther, 2005, 5(3): 285-297.
[12]Mori S, Wang L, Takeuchi T, et al. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein[J]. Virology, 2004, 330(2): 375-383.
[13]Ding W, Zhang L, Yan Z, et al. Intracellular trafficking of adeno-associated viral vectors[J]. GeneTher, 2005, 12 (11): 873-880.
[14]Xiao W, Chirmule N, Berta SC, et al. Gene therapy vectors based on adeno-associated virus type 1[J]. J Virol, 1999, 73(5): 3994-4003.
[15]Chao H, Liu Y, Rabinowitz J, et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors [J]. Mol Ther, 2000, 2(6): 619-623.
[16]Handa A, Muramatsu S, Qiu J, et al. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors [J]. J Gen Virol, 2000, 81(Pt 8): 2077-2084.
[17]Davidson BL, Stein CS, Heth JA, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors transduction of variant cell types and regions in the mammalian central nervous system [J]. Proc NatI Acad Sci USA, 2000, 97(7): 3428-3432.
[18]McMahon JM, Conroy S, Lyons M, et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors [J]. Stem Cells Dev, 2006, 15(1): 87-96.
上一页 [1] [2] [3] [4] [5] [6] [7] 下一页